New data from an international collaborative study on TP53 and colorectal cancer, including data from the Lothe lab
TP53, a master key in cancer. Mutations, functional consequences and clinical end-points in colorectal cancer are reported in meta-analyses. Ann Oncol. 2006 Mar 8; [Epub ahead of print], J Clin Oncol. 2005 Oct 20;23(30):7518-28.
An international study group including 17 countries have recently published two papers in relation to "TP53 mutations in colorectal cancers and their functional clinical consequences". The study included a total of 3583 patients and 221 of these were Norwegian, analysed in the Lothe lab.
An international study group including 17 countries have recently published two papers in relation to "TP53 mutations in colorectal cancers and their functional clinical consequences". The study included a total of 3583 patients and 221 of these were Norwegian, analysed in the Lothe lab.